Trials / Recruiting
RecruitingNCT06836492
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors: a Single Arm Trial.
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Yizhuo Zhang · Academic / Other
- Sex
- All
- Age
- 0 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose is to explore the efficacy and safety of the SYSUCC-RMS regimen for pediatric RMS patients and to explore the impact of concurrent radiotherapy and chemotherapy on the survival rate of low-risk, medium risk, high-risk, and extremely high-risk patients in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | VAC，VAC/VII，CAV/IE | Low risk: VAC Intermediate risk: VAC/VII High risk: CAV/IE Very high risk: CAV/VIP |
Timeline
- Start date
- 2017-01-30
- Primary completion
- 2029-09-01
- Completion
- 2029-12-01
- First posted
- 2025-02-20
- Last updated
- 2025-02-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06836492. Inclusion in this directory is not an endorsement.